Fisher Asset Management
CGON icon

Fisher Asset Management’s CG Oncology CGON Stock Holding History

Fisher Asset Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.5M Sell
456,978
-8,055
-2% -$527K 0.01% 292
2026
Q1 		$31.5M Buy
+465,033
New +$26.3M 0.01% 280

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fisher Asset Management's CGON Position: Q2 2026 in Review

Fisher Asset Management reduced its CG Oncology (CGON) stake by 1.7% in Q2 2026, selling an estimated $527K and leaving 456,978 shares worth $32.5M. The position accounts for 0.01% of the portfolio, ranked #292.

Fisher Asset Management first reported a position in CGON in Q1 2026 and has held it in 2 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Fisher Asset Management held 456,978 shares of CG Oncology worth $32.5M as of Q2 2026.
  • Fisher Asset Management sold 8,055 CG Oncology shares in Q2 2026, an estimated $527K.
  • CG Oncology made up 0.01% of Fisher Asset Management's portfolio in Q2 2026, its #292 holding.
  • Fisher Asset Management first reported a position in CG Oncology in Q1 2026 and has held it in 2 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.